These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1983 related articles for article (PubMed ID: 28267621)

  • 1. Targeting hepatic macrophages to treat liver diseases.
    Tacke F
    J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
    Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
    Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage heterogeneity in liver injury and fibrosis.
    Tacke F; Zimmermann HW
    J Hepatol; 2014 May; 60(5):1090-6. PubMed ID: 24412603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.
    van der Heide D; Weiskirchen R; Bansal R
    Front Immunol; 2019; 10():2852. PubMed ID: 31849997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
    Baeck C; Wei X; Bartneck M; Fech V; Heymann F; Gassler N; Hittatiya K; Eulberg D; Luedde T; Trautwein C; Tacke F
    Hepatology; 2014 Mar; 59(3):1060-72. PubMed ID: 24481979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage Phenotype and Function in Liver Disorder.
    Dou L; Shi X; He X; Gao Y
    Front Immunol; 2019; 10():3112. PubMed ID: 32047496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
    Miura K; Yang L; van Rooijen N; Ohnishi H; Seki E
    Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1310-21. PubMed ID: 22442158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.
    Tosello-Trampont AC; Landes SG; Nguyen V; Novobrantseva TI; Hahn YS
    J Biol Chem; 2012 Nov; 287(48):40161-72. PubMed ID: 23066023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocytes and macrophages as cellular targets in liver fibrosis.
    Heymann F; Trautwein C; Tacke F
    Inflamm Allergy Drug Targets; 2009 Sep; 8(4):307-18. PubMed ID: 19534673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic plasticity of macrophage functions in diseased liver.
    Ritz T; Krenkel O; Tacke F
    Cell Immunol; 2018 Aug; 330():175-182. PubMed ID: 29454647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The innate immune receptor TREM-1 promotes liver injury and fibrosis.
    Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Arbab AS; Dzutsev A; Sadek R; Trinchieri G; Horuzsko A
    J Clin Invest; 2018 Nov; 128(11):4870-4883. PubMed ID: 30137027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
    Karlmark KR; Weiskirchen R; Zimmermann HW; Gassler N; Ginhoux F; Weber C; Merad M; Luedde T; Trautwein C; Tacke F
    Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis.
    Zimmermann HW; Tacke F
    Inflamm Allergy Drug Targets; 2011 Dec; 10(6):509-36. PubMed ID: 22150762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Macrophage Diversity in Health and Disease.
    Horn P; Tacke F
    Results Probl Cell Differ; 2024; 74():175-209. PubMed ID: 39406906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities.
    Wen Y; Lambrecht J; Ju C; Tacke F
    Cell Mol Immunol; 2021 Jan; 18(1):45-56. PubMed ID: 33041338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo.
    Tacke F
    Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S27. PubMed ID: 23259611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages in the Aging Liver and Age-Related Liver Disease.
    Stahl EC; Haschak MJ; Popovic B; Brown BN
    Front Immunol; 2018; 9():2795. PubMed ID: 30555477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.